In a groundbreaking study, researchers at Stellenbosch University have unveiled the presence of a rarely observed class of phenolic compounds—known as flavoalkaloids—in the leaves of Cannabis plants. This marks the first report of such compounds in Cannabis, opening fresh avenues for medical and biochemical research.
Key Findings
- The team employed advanced analytical instrumentation, combining two-dimensional liquid chromatography with high-resolution mass spectrometry, to profile the phenolic compounds present in three commercially cultivated Cannabis strains.
- They identified a total of 79 phenolic substances, 25 of which are novel to Cannabis. Among these, sixteen compounds were tentatively classified as flavoalkaloids.
- Notably, these flavoalkaloids were predominantly detected in the leaves of one of the three strains studied.
Significance
The detection of flavoalkaloids is particularly compelling because, while flavonoids are commonly found across the plant kingdom and are well known for their antioxidant, anti-inflammatory, and anti-carcinogenic properties, flavoalkaloids are extremely rare. Their presence in Cannabis suggests that this plant’s biochemical complexity is underappreciated.
As Dr. Magriet Muller, the study’s lead author, observes, the low concentrations and vast structural diversity of phenolic compounds make them difficult to analyze. This discovery underscores how powerful analytical techniques can uncover hidden molecular diversity even in well-studied species.
Implications for Biomedical Research
Professor André de Villiers, who led the research, emphasizes that much of the prior cannabis research has focused on cannabinoids—substances responsible for the plant’s psychoactive effects. However, the current findings indicate that non-cannabinoid phenolics, including novel flavoalkaloids, might hold untapped medicinal potential.
Leaf materials of Cannabis, often discarded as waste, may therefore harbour valuable compounds. The variation in phenolic profiles between strains also suggests potential for selective breeding or strain-specific applications in pharmaceuticals or nutraceuticals.
Source: Stellenbosch University
Dabbin-Dad Newsroom
